Copyright Reports & Markets. All rights reserved.

Global Gastric Cancer Testing, Treatment and Prevention Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Gastric Cancer Testing, Treatment and Prevention Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Test
      • 1.4.3 Treatment
      • 1.4.4 Prevention
    • 1.5 Market by Application
      • 1.5.1 Global Gastric Cancer Testing, Treatment and Prevention Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Gastric Cancer Testing, Treatment and Prevention Market Size
    • 2.2 Gastric Cancer Testing, Treatment and Prevention Growth Trends by Regions
      • 2.2.1 Gastric Cancer Testing, Treatment and Prevention Market Size by Regions (2014-2025)
      • 2.2.2 Gastric Cancer Testing, Treatment and Prevention Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Gastric Cancer Testing, Treatment and Prevention Market Size by Manufacturers
      • 3.1.1 Global Gastric Cancer Testing, Treatment and Prevention Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Gastric Cancer Testing, Treatment and Prevention Market Concentration Ratio (CR5 and HHI)
    • 3.2 Gastric Cancer Testing, Treatment and Prevention Key Players Head office and Area Served
    • 3.3 Key Players Gastric Cancer Testing, Treatment and Prevention Product/Solution/Service
    • 3.4 Date of Enter into Gastric Cancer Testing, Treatment and Prevention Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Gastric Cancer Testing, Treatment and Prevention Market Size by Type (2014-2019)
    • 4.2 Global Gastric Cancer Testing, Treatment and Prevention Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Gastric Cancer Testing, Treatment and Prevention Market Size (2014-2019)
    • 5.2 Gastric Cancer Testing, Treatment and Prevention Key Players in United States
    • 5.3 United States Gastric Cancer Testing, Treatment and Prevention Market Size by Type
    • 5.4 United States Gastric Cancer Testing, Treatment and Prevention Market Size by Application

    6 Europe

    • 6.1 Europe Gastric Cancer Testing, Treatment and Prevention Market Size (2014-2019)
    • 6.2 Gastric Cancer Testing, Treatment and Prevention Key Players in Europe
    • 6.3 Europe Gastric Cancer Testing, Treatment and Prevention Market Size by Type
    • 6.4 Europe Gastric Cancer Testing, Treatment and Prevention Market Size by Application

    7 China

    • 7.1 China Gastric Cancer Testing, Treatment and Prevention Market Size (2014-2019)
    • 7.2 Gastric Cancer Testing, Treatment and Prevention Key Players in China
    • 7.3 China Gastric Cancer Testing, Treatment and Prevention Market Size by Type
    • 7.4 China Gastric Cancer Testing, Treatment and Prevention Market Size by Application

    8 Japan

    • 8.1 Japan Gastric Cancer Testing, Treatment and Prevention Market Size (2014-2019)
    • 8.2 Gastric Cancer Testing, Treatment and Prevention Key Players in Japan
    • 8.3 Japan Gastric Cancer Testing, Treatment and Prevention Market Size by Type
    • 8.4 Japan Gastric Cancer Testing, Treatment and Prevention Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Gastric Cancer Testing, Treatment and Prevention Market Size (2014-2019)
    • 9.2 Gastric Cancer Testing, Treatment and Prevention Key Players in Southeast Asia
    • 9.3 Southeast Asia Gastric Cancer Testing, Treatment and Prevention Market Size by Type
    • 9.4 Southeast Asia Gastric Cancer Testing, Treatment and Prevention Market Size by Application

    10 India

    • 10.1 India Gastric Cancer Testing, Treatment and Prevention Market Size (2014-2019)
    • 10.2 Gastric Cancer Testing, Treatment and Prevention Key Players in India
    • 10.3 India Gastric Cancer Testing, Treatment and Prevention Market Size by Type
    • 10.4 India Gastric Cancer Testing, Treatment and Prevention Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Gastric Cancer Testing, Treatment and Prevention Market Size (2014-2019)
    • 11.2 Gastric Cancer Testing, Treatment and Prevention Key Players in Central & South America
    • 11.3 Central & South America Gastric Cancer Testing, Treatment and Prevention Market Size by Type
    • 11.4 Central & South America Gastric Cancer Testing, Treatment and Prevention Market Size by Application

    12 International Players Profiles

    • 12.1 Biogen Idec
      • 12.1.1 Biogen Idec Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Gastric Cancer Testing, Treatment and Prevention Introduction
      • 12.1.4 Biogen Idec Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2014-2019)
      • 12.1.5 Biogen Idec Recent Development
    • 12.2 Bristol Myers Squibb
      • 12.2.1 Bristol Myers Squibb Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Gastric Cancer Testing, Treatment and Prevention Introduction
      • 12.2.4 Bristol Myers Squibb Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2014-2019)
      • 12.2.5 Bristol Myers Squibb Recent Development
    • 12.3 Eli Lilly And Company
      • 12.3.1 Eli Lilly And Company Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Gastric Cancer Testing, Treatment and Prevention Introduction
      • 12.3.4 Eli Lilly And Company Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2014-2019)
      • 12.3.5 Eli Lilly And Company Recent Development
    • 12.4 Glaxosmithkline Genentech, Inc
      • 12.4.1 Glaxosmithkline Genentech, Inc Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Gastric Cancer Testing, Treatment and Prevention Introduction
      • 12.4.4 Glaxosmithkline Genentech, Inc Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2014-2019)
      • 12.4.5 Glaxosmithkline Genentech, Inc Recent Development
    • 12.5 Hoffmann-La Roche Inc.
      • 12.5.1 Hoffmann-La Roche Inc. Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Gastric Cancer Testing, Treatment and Prevention Introduction
      • 12.5.4 Hoffmann-La Roche Inc. Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2014-2019)
      • 12.5.5 Hoffmann-La Roche Inc. Recent Development
    • 12.6 Immunogen Merck & Company
      • 12.6.1 Immunogen Merck & Company Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Gastric Cancer Testing, Treatment and Prevention Introduction
      • 12.6.4 Immunogen Merck & Company Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2014-2019)
      • 12.6.5 Immunogen Merck & Company Recent Development
    • 12.7 Novartis
      • 12.7.1 Novartis Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Gastric Cancer Testing, Treatment and Prevention Introduction
      • 12.7.4 Novartis Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2014-2019)
      • 12.7.5 Novartis Recent Development
    • 12.8 Pacific Edge Diagnostics Nz
      • 12.8.1 Pacific Edge Diagnostics Nz Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Gastric Cancer Testing, Treatment and Prevention Introduction
      • 12.8.4 Pacific Edge Diagnostics Nz Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2014-2019)
      • 12.8.5 Pacific Edge Diagnostics Nz Recent Development
    • 12.9 Pfizer
      • 12.9.1 Pfizer Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Gastric Cancer Testing, Treatment and Prevention Introduction
      • 12.9.4 Pfizer Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2014-2019)
      • 12.9.5 Pfizer Recent Development
    • 12.10 Roche/Genentech Oncolytics
      • 12.10.1 Roche/Genentech Oncolytics Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Gastric Cancer Testing, Treatment and Prevention Introduction
      • 12.10.4 Roche/Genentech Oncolytics Revenue in Gastric Cancer Testing, Treatment and Prevention Business (2014-2019)
      • 12.10.5 Roche/Genentech Oncolytics Recent Development
    • 12.11 Zova Biotherapeutics Inc.

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Stomach cancer begins when cancer cells form in the inner lining of your stomach. These cells can grow into a tumor. Also called gastric cancer, the disease usually grows slowly over many years. There may be no symptoms of stomach cancer early on. Later, symptoms include feeling bloated after eating, feeling full after eating small amounts of food, nausea, heartburn, or indigestion.
      In 2018, the global Gastric Cancer Testing, Treatment and Prevention market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Gastric Cancer Testing, Treatment and Prevention status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gastric Cancer Testing, Treatment and Prevention development in United States, Europe and China.

      The key players covered in this study
      Biogen Idec
      Bristol Myers Squibb
      Eli Lilly And Company
      Glaxosmithkline Genentech, Inc
      Hoffmann-La Roche Inc.
      Immunogen Merck & Company
      Novartis
      Pacific Edge Diagnostics Nz
      Pfizer
      Roche/Genentech Oncolytics
      Zova Biotherapeutics Inc.

      Market segment by Type, the product can be split into
      Test
      Treatment
      Prevention

      Market segment by Application, split into
      Hospitals
      Clinics
      Other

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Gastric Cancer Testing, Treatment and Prevention status, future forecast, growth opportunity, key market and key players.
      To present the Gastric Cancer Testing, Treatment and Prevention development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Gastric Cancer Testing, Treatment and Prevention are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now